Me Today (MEE) / HY24

Revenue -37% and cash exhausted; debt restructure now critical for MEE

EBITDA losses narrowed sharply but a PBT loss of NZ$7.3m and zero cash leave the balance sheet dependent on a proposed capital raise to survive.

Release date
28 February 2024
Published
21 April 2026

What changed

Revenue fell 36.8% to NZ$2.3m from NZ$3.6m in HY23, driven almost entirely by the Honey segment, which collapsed from NZ$2.5m to NZ$1.2m and lost nearly 20 percentage points of revenue share. All three segments — Honey, Sale of Goods, and Agency Services — remained loss-making on an EBITDA basis.

Despite the revenue decline, operating EBITDA improved 27.7%, with the loss narrowing from NZ$3.1m to NZ$2.2m. That improvement did not survive the full P&L: PBT loss widened 24.9% to NZ$7.3m from NZ$5.8m, indicating the gap between EBITDA and PBT was materially larger this half, likely reflecting the write-down of a customer relationship asset noted in the release.

On the cash side, operating outflow improved meaningfully to NZ$1.9m from NZ$4.6m. However, cash on hand fell to nil from NZ$2.3m a year earlier. Gross borrowings rose NZ$1.4m to NZ$13.7m and now include a NZ$1.2m bank overdraft, implying net debt of approximately NZ$13.7m — up from NZ$10.0m in HY23. Total equity collapsed 75.7% to NZ$4.6m, reflecting accumulated losses burning through the capital base.

What matters

The gap between EBITDA improvement and PBT deterioration is the central tension. The NZ$0.9m narrowing of the EBITDA loss is real in the sense that cash operating costs fell faster than revenue. But the PBT loss widened by NZ$1.4m, pointing to a significant non-cash charge — the customer relationship asset write-down — sitting between the two lines. Until a fully itemised reconciliation is published, the quality of the EBITDA improvement cannot be cleanly assessed.

The balance sheet is at an inflection point. Cash is exhausted, the company carries a NZ$1.2m overdraft, and equity stands at NZ$4.6m against NZ$13.7m of gross borrowings. The proposed capital raise of up to NZ$2.78m and associated debt restructure are not yet completed. If they do not close, the going-concern position becomes acute given the continuing cash burn rate.

Working capital has deteriorated structurally relative to revenues. Receivable days expanded from 86 to 170, and inventory days now stand at approximately 1,138 versus 791 in HY23 — a consequence of revenues shrinking faster than inventory. The NZ$14.2m inventory balance against NZ$2.3m of half-year revenue is an acute mismatch that constrains liquidity and raises questions about inventory realisability.

Expectations

No quantitative guidance was provided by management for HY24 or FY24, and no forward-order book figure was disclosed. Assessment against stated targets is therefore not possible.

What the release does support is a structural revenue downshift. HY24 revenue annualises to approximately NZ$4.6m, roughly 58% of the FY23 base of NZ$7.9m. FY23 itself was already a declining business, so the trajectory is a meaningful step down rather than a seasonal dip. Using the FY23 shape as a rough guide, HY23 represented approximately 45.7% of full-year FY23 revenue, suggesting the second half has historically been slightly larger — but with the Honey segment severely impaired, that historical weighting provides limited comfort.

The release frames the capital raise and debt restructure as providing the "underlying stability" needed for the business to continue operating. That language does not constitute forward guidance; it is a solvency-oriented framing.

Quality of result

The headline EBITDA improvement is partially real — cash operating costs fell — but it is also partly structural deterioration dressed as improvement: a smaller business is cheaper to run. The 36.8% revenue decline means the EBITDA cost base has been cut substantially, yet all three segments still generated EBITDA losses. There is no evidence of a path to positive EBITDA at current revenue levels without further restructuring.

The NZ$2.7m improvement in operating cash flow is the most credible positive in the result. However, it was materially aided by inventory liquidation (inventories declined NZ$1.4m), which is a one-directional working-capital release, not a recurring improvement. Against this, receivables grew NZ$0.4m despite lower revenues — a deterioration in collection quality. Cash conversion of EBITDA is not a clean metric when both EBITDA and OCF are negative and moving in different directions.

The customer relationship asset write-down, which drove the wedge between EBITDA improvement and PBT deterioration, is a non-cash item but is evidence of asset impairment in the core book. The balance sheet is now heavily weighted toward inventory (NZ$14.2m) relative to the group's revenue-generating capacity, and the realisable value of that inventory is not independently verified in this filing.

Unresolved

  • The exact quantum and accounting treatment of the customer relationship asset write-down is not fully disclosed in the extracted data; without it, the bridge from operating EBITDA of -NZ$2.2m to PBT of -NZ$7.3m cannot be independently reconstructed.
  • The terms, conditions, and execution risk of the up-to-NZ$2.78m capital raise and debt restructure are not detailed; the company's ability to continue as a going concern is contingent on these closing.
  • Inventory realisability is unverified: NZ$14.2m of inventory against NZ$2.3m of half-year revenue implies an implausible turnover cycle, and any impairment of that book would materially erode the remaining NZ$4.6m equity cushion.
  • The Honey segment's sharp revenue decline is unexplained beyond the numbers; whether this reflects channel disruption, pricing pressure, contract loss, or deliberate rationalisation cannot be determined from this filing.

This briefing cannot assess whether the proposed capital raise and debt restructure will be successfully executed or whether the going-concern basis of accounting remains appropriate.

Key metrics

← Swipe to view more
Metric HY24 HY23 Change
Revenue $2.3m $3.6m -36.8% ↓
EBITDA −$2.2m −$3.1m +27.7% ↑
Net profit after tax −$7.3m −$5.8m -24.9% ↓
Net cash inflow from operating activities −$1.9m −$4.6m +58.6% ↑
Operating profit −$3.0m −$5.0m +41.1% ↑
Profit before tax −$7.3m −$5.8m -24.9% ↓
Cash and cash equivalents $0m $2.3m -100.0% ↓
Total assets $20.7m $33.9m -39.2% ↓

Source: annolyse.ai/briefings/mee-hy24

Segment breakdown

← Swipe to view more
Segment Current revenue Prior revenue Current result Mix shift
Sale of goods $0.8m $0.8m −$0.7m +13.7pp
Agency services $0.3m $0.3m −$0.1m +5.5pp
Honey $1.1m $2.5m −$0.8m -19.2pp

Source: annolyse.ai/briefings/mee-hy24

Analytical metrics

← Swipe to view more
Metric HY24 HY23 Context
OCF / EBITDA (cash conversion) 86.4% 150.9% deteriorated
FCF pre-lease −$1.9m −$4.7m +$2.7m
FCF / NPAT 26.6% 80.2% complementary conversion metric
Capex % revenue 0.4% 0.4%
Capex −$0.0m −$0.0m +$0.0m
Debtor days 170.4 86.2 +84.2 days
Inventory days 1137.8 791.0 +346.8 days
Trade debtors $2.1m $1.7m +$0.4m
Net debt $13.7m $10.0m +$3.7m
Gross borrowings $13.7m $12.3m +$1.4m
ROE (annualised) -156.6% -30.5% Weakening
Profit from continuing operations −$7.3m −$5.8m −$1.4m

Source: annolyse.ai/briefings/mee-hy24


This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Appendix

Source documents

The filings and announcement documents considered in this briefing.

Current period

31 December 2023 Financial Statements - Market Announcement

HY24 / results release

Me Today HY23 Interim Financial Statements 6 months ended 31 December 2023

HY24 / financial report

Prior comparable period

31 December 2022 Financial Statements - Market Announcement

HY23 / results release

Me Today HY23 Interim Financial Statements 6 months ended 31 December 2022

HY23 / financial report

Full-year context

30 June 2023 Financial Statements - Market Announcement

FY23 / results release

Me Today - Financial Statements 12 months ended 30 June 2023

FY23 / financial report

Subscribe

Want briefings like this for the next reporting season?

Annolyse is being built as a publication product first. Subscribe for the next release.